[
  {
    "ts": "2026-01-07T10:00:00+00:00",
    "headline": "Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical",
    "summary": "Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic’s Cell-Seq platform for the discovery of novel therapeutic targets. “This collaboration with Ono Pharmaceutical represents another strong validation of our platform’s ability to uncover new disease biology and identify novel targets for rare and common indications,” said",
    "url": "https://finance.yahoo.com/news/scenic-biotech-enters-license-research-100000020.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "0bf17e97-0ae1-3e1b-bdbe-c60d2c3d99fb",
      "content": {
        "id": "0bf17e97-0ae1-3e1b-bdbe-c60d2c3d99fb",
        "contentType": "STORY",
        "title": "Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical",
        "description": "",
        "summary": "Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic’s Cell-Seq platform for the discovery of novel therapeutic targets. “This collaboration with Ono Pharmaceutical represents another strong validation of our platform’s ability to uncover new disease biology and identify novel targets for rare and common indications,” said",
        "pubDate": "2026-01-07T10:00:00Z",
        "displayTime": "2026-01-07T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f3c92d6a92a356b689039c33cf879964",
          "originalWidth": 1200,
          "originalHeight": 434,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lAjiTNmRG0.Ss9XknecrMQ--~B/aD00MzQ7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f3c92d6a92a356b689039c33cf879964.cf.webp",
              "width": 1200,
              "height": 434,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D_peJ4xkwgcevfSdGfXIeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f3c92d6a92a356b689039c33cf879964.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/scenic-biotech-enters-license-research-100000020.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/scenic-biotech-enters-license-research-100000020.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OPHLF"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ALNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T14:00:04+00:00",
    "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-140004056.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6b1a9cf0-6618-3619-9b6f-ff97d18d6b21",
      "content": {
        "id": "6b1a9cf0-6618-3619-9b6f-ff97d18d6b21",
        "contentType": "STORY",
        "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
        "description": "",
        "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
        "pubDate": "2026-01-07T14:00:04Z",
        "displayTime": "2026-01-07T14:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9.bMA28djqdXWkJ0xgkrvA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yGQaN1QLRXutAaqBqcTUKw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-140004056.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-140004056.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T16:35:49+00:00",
    "headline": "Should You Chase the Rally in Alumis Stock Today?",
    "summary": "Alumis shares soar as the biotech firm’s envudeucitinib meets all primary and secondary endpoints in a Phase 3 trial. Here’s how you should play ALMS shares in 2026.",
    "url": "https://www.barchart.com/story/news/36930672/should-you-chase-the-rally-in-alumis-stock-today",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "c3ce47a3-9bb9-3ca9-8a48-787e69dc48e9",
      "content": {
        "id": "c3ce47a3-9bb9-3ca9-8a48-787e69dc48e9",
        "contentType": "STORY",
        "title": "Should You Chase the Rally in Alumis Stock Today?",
        "description": "",
        "summary": "Alumis shares soar as the biotech firm’s envudeucitinib meets all primary and secondary endpoints in a Phase 3 trial. Here’s how you should play ALMS shares in 2026.",
        "pubDate": "2026-01-07T16:35:49Z",
        "displayTime": "2026-01-07T16:35:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/754d1add9645fb46c7ad31fc4fa63ccc",
          "originalWidth": 1600,
          "originalHeight": 1038,
          "caption": "Stock exchange financial or forex graph by Bigc Studio via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rVpZE7yOuMtu5ThdGK8Y5Q--~B/aD0xMDM4O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/754d1add9645fb46c7ad31fc4fa63ccc.cf.webp",
              "width": 1600,
              "height": 1038,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6diRt2JefKs07rA2CWiSdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/754d1add9645fb46c7ad31fc4fa63ccc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36930672/should-you-chase-the-rally-in-alumis-stock-today",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/chase-rally-alumis-stock-today-163549709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALMS"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T21:20:00+00:00",
    "headline": "3 Drug Stocks to Buy at a Discount",
    "summary": "The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap industry giants to consider.",
    "url": "https://www.fool.com/investing/2026/01/07/3-drug-stocks-to-buy-at-a-discount/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ceb8fea2-15df-3ba3-9ab5-45ae1d883b70",
      "content": {
        "id": "ceb8fea2-15df-3ba3-9ab5-45ae1d883b70",
        "contentType": "STORY",
        "title": "3 Drug Stocks to Buy at a Discount",
        "description": "",
        "summary": "The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap industry giants to consider.",
        "pubDate": "2026-01-07T21:20:00Z",
        "displayTime": "2026-01-07T21:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/4f71bf990154afb24c7a9a05250a0185",
          "originalWidth": 1369,
          "originalHeight": 800,
          "caption": "A finger flipping dice that spell out long term and short term.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A02CqIBRKDDimBJfuetC5Q--~B/aD04MDA7dz0xMzY5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4f71bf990154afb24c7a9a05250a0185.cf.webp",
              "width": 1369,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Nz1FKdFVpAkt9roiVdww2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/4f71bf990154afb24c7a9a05250a0185.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/07/3-drug-stocks-to-buy-at-a-discount/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-drug-stocks-buy-discount-212000896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]